ReviewEuropean cardiology2025

Adjudication of Adverse Cardiovascular Events in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib: Deaths in GLOW or Blowing in the Wind?

Roberta Esposito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.